Detalhe da pesquisa
1.
Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity.
Gut
; 63(11): 1769-81, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24555999
2.
Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma.
Cancer Immunol Res
; 7(6): 977-989, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028033
3.
Issues in biomedical research data management and analysis: needs and barriers.
J Am Med Inform Assoc
; 14(4): 478-88, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17460139
4.
A simple quantitative assay for the activity of thymidine kinase 1 in solid tumors.
Nucl Med Biol
; 34(6): 619-23, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17707801
5.
Evaluation of 5'-deoxy-5'-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activity.
Nucl Med Biol
; 34(5): 471-8, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17591546
6.
T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.
Cancer Cell
; 28(5): 638-652, 2015 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26525103
7.
Tumor 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of (18)F-FLT PET studies in lung tumors.
J Nucl Med
; 52(8): 1181-8, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21764789
8.
Synthesis and in vitro evaluation of 5-fluoro-6-[(2-iminopyrrolidin-1-YL)methyl]uracil, TPI(F): an inhibitor of human thymidine phosphorylase (TP).
Nucleosides Nucleotides Nucleic Acids
; 29(1): 49-54, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20391192
9.
Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation.
J Histochem Cytochem
; 57(11): 1087-97, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19654105